Authors:
GRAF WD
OLEINIK OE
GLAUSER TA
MAERTENS P
EDER DN
PIPPENGER CE
Citation: Wd. Graf et al., ALTERED ANTIOXIDANT ENZYME-ACTIVITIES IN CHILDREN WITH A SERIOUS ADVERSE EXPERIENCE RELATED TO VALPROIC ACID THERAPY, Neuropediatrics, 29(4), 1998, pp. 195-201
Authors:
VANDYK EO
SCHELLENBERG KA
VANDYK QF
PIPPENGER CE
BLANCO A
SHAEFFER J
Citation: Eo. Vandyk et al., PROTECTIVE EFFECTS OF POLYETHYLENE-GLYCOL AGAINST RADIATION-INDUCED INJURIES IN AURELIA-AURITA AND THE PRESENCE OF FREE-RADICAL SCAVENGING ENZYMES, Radiology, 209P, 1998, pp. 988-988
Citation: Da. Svinarov et Ce. Pippenger, RELATIONSHIPS BETWEEN CARBAMAZEPINE-DIOL, CARBAMAZEPINE-EPOXIDE, AND CARBAMAZEPINE TOTAL AND FREE STEADY-STATE CONCENTRATIONS IN EPILEPTIC PATIENTS - THE INFLUENCE OF AGE, SEX, AND COMEDICATION, Therapeutic drug monitoring, 18(6), 1996, pp. 660-665
Authors:
GRAF WD
OLEINIK OE
PIPPENGER CE
EDER DN
GLAUSER TA
SHURTLEFF DB
Citation: Wd. Graf et al., COMPARISON OF ERYTHROCYTE ANTIOXIDANT ENZYME-ACTIVITIES AND EMBRYOLOGIC LEVEL OF NEURAL-TUBE DEFECTS, European journal of pediatric surgery, 5, 1995, pp. 8-11
Citation: Ta. Glauser et al., EFFECT OF AGE, RACE, AND GENDER ON ANTIOXIDANT DEFENSES IN HEALTHY-CHILDREN, Annals of neurology, 38(3), 1995, pp. 543-543
Authors:
GLAUSER TA
DONALDSON J
PIPPENGER CE
GLAUSER SC
Citation: Ta. Glauser et al., IDENTIFYING CHILDREN AT HIGH-RISK FOR IDIOSYNCRATIC ANTICONVULSANT DRUG-REACTIONS - THE CALCULATED OXIDATIVE PROTECTION RATIOS, Annals of neurology, 38(3), 1995, pp. 543-543
Citation: Mg. Chez et al., SUPEROXIDE-DISMUTASE OVER ACTIVITY, EXCESSIVE SELENIUM, AND LOW COPPER IN ACQUIRED EPILEPTIC APHASIA (THE LANDAU-KLEFFNER SYNDROME), Annals of neurology, 38(3), 1995, pp. 544-544
Authors:
LINDAY LA
PIPPENGER CE
HOWARD A
LIEBERMAN JA
Citation: La. Linday et al., FREE-RADICAL SCAVENGING ENZYME-ACTIVITY AND RELATED TRACE-METALS IN CLOZAPINE-INDUCED AGRANULOCYTOSIS - A PILOT-STUDY, Journal of clinical psychopharmacology, 15(5), 1995, pp. 353-360
Citation: Da. Svinarov et Ce. Pippenger, VALPROIC ACID-CARBAMAZEPINE INTERACTION - IS VALPROIC ACID A SELECTIVE INHIBITOR OF EPOXIDE HYDROLASE, Therapeutic drug monitoring, 17(3), 1995, pp. 217-220
Citation: Rw. Hurd et al., N-ACETYLCYSTEINE IN THE TREATMENT OF NEURO-DEGENERATIVE DISEASE - 18-MONTH FOLLOW-UP IN PATIENTS WITH PROGRESSIVE MYOCLONUS EPILEPSY, Neurology, 45(4), 1995, pp. 181-181
Citation: Ta. Glauser et al., LONGITUDINAL EFFECT OF VALPROIC ACID THERAPY ON CARNITINE AND VITAMINCONCENTRATIONS IN CHILDREN, Epilepsia, 36, 1995, pp. 535-535
Citation: Wd. Graf et al., ERYTHROCYTE ANTIOXIDANT ENZYME-ACTIVITIES IN CHILDREN WITH MYELOMENINGOCELE, Developmental Medicine and Child Neurology, 37(10), 1995, pp. 900-905
Authors:
CHEZ MG
BOURGEOIS BFD
PIPPENGER CE
KNOWLES WD
Citation: Mg. Chez et al., PHARMACODYNAMIC INTERACTIONS BETWEEN PHENYTOIN AND VALPROATE - INDIVIDUAL AND COMBINED ANTIEPILEPTIC AND NEUROTOXIC ACTIONS IN MICE, Clinical neuropharmacology, 17(1), 1994, pp. 32-37
Citation: Ta. Glauser et al., GLUTATHIONE-PEROXIDASE DEFICIENCY IN CHILDHOOD EPILEPTIC ENCEPHALOPATHY (THE LENNOX-GASTAUT SYNDROME), Pediatric research, 35(4), 1994, pp. 10000380-10000380
Citation: Rw. Hurd et al., THE ROLE OF COPPER IN THE DIFFERING EFFECTS OF VALPROIC ACID (VPA) AND PHENYTOIN (PHT) IN PROGRESSIVE MYOCLONUS EPILEPSY OF THE UNVERRICHT-LUNDBORG TYPE (PME-UL), Neurology, 44(4), 1994, pp. 10000295-10000295